[1] |
李文忠. 现代麻风病学[M]. 上海: 上海科学出版社, 2006:1⁃35.
|
[2] |
中华人民共和国国家卫生和计划生育委员会. WS291⁃2018 麻风病诊断[S]. 北京, 2018.
|
[3] |
张国成, 严良斌, 沈建平, 等. 全国消除麻风病危害规划实施工作指南[M]. 南京: 江苏科学技术出版社, 2013:1⁃93.
|
[4] |
龙思宇, 余美文, 严良斌, 等. 2011—2015年中国麻风病流行病学特征分析[J]. 中华皮肤科杂志, 2017,50(6):400⁃403. doi: 10.3760/cma.j.issn.0412⁃4030.2017.06.003.
|
[5] |
余美文, 张国成, 严良斌, 等. 2001—2010年中国麻风病流行病学特征分析[J]. 中华皮肤科杂志, 2012,45(6):381⁃383. doi: 10.3760/cma.j.issn.0412⁃4030.2012.06.001.
|
[6] |
WHO. Global leprosy update, 2016: accelerating reduction of disease burden[J]. Wkly Epidemiol Rec, 2017,92:501⁃519.
|
[7] |
WHO. Global leprosy update, 2017: reducing the disease burden due to leprosy[J]. Wkly Epidemiol Rec, 2018,93:445⁃456.
|
[8] |
WHO. Global leprosy update, 2018: moving towards a leprosy⁃free world[J]. Wkly Epidemiol Rec, 2019,94:389⁃412.
|
[9] |
WHO. Global leprosy (Hansen disease) update, 2019: time to set⁃up prevention initiatives[J]. Wkly Epidemiol Rec, 2020,95:417⁃440.
|
[10] |
WHO. Global leprosy (Hansen disease) update, 2020: impact of COVID⁃19 on global leprosy control[J]. Wkly Epidemiol Rec, 2021,96:421⁃444.
|
[11] |
Sun PW, Wang L, Yu MW, et al. Leprosy statistics in China, 2017[J]. Int J Dermatol Venereol,2019,2(1):1⁃5. doi: 10.3760/cma.j.issn.2096⁃5540.2019.01.001.
|
[12] |
Wang L, Sun PW, Yu MW, et al. Leprosy update in China, 2019[J]. Int J Dermatol Venereol, 2022,5(1):15⁃19. doi: 10.1097/JD9.0000000000000178.
|
[13] |
余美文, 沈建平, 陈祥生, 等. 1989—1998年中国儿童麻风发病和临床分析[J]. 中华皮肤科杂志, 2000,33(z1):18⁃22. doi: 10.3760/j.issn:0412⁃4030.2000.z1.007.
|
[14] |
Vieira M, Nery JS, Paixão ES, et al. Leprosy in children under 15 years of age in Brazil: a systematic review of the literature[J]. PLoS Negl Trop Dis, 2018,12(10):e0006788. doi: 10.1371/journal.pntd.0006788.
|
[15] |
Rahevar K, Morishita F, Oh KH, et al. Epidemiological review of leprosy in WHO′s Western Pacific Region: 1991-2019[J]. Western Pac Surveill Response J, 2021,12(3):34⁃46. doi: 10.5365/wpsar.2021.12.3.858.
|
[16] |
曾凡荣, 吴李梅, 费丽娟, 等. 浙江省流动人口新发麻风病例流行病学特征分析[J]. 中国麻风皮肤病杂志, 2020,36(7):426⁃428. doi: 10.12144/zgmfskin202007426.
|
[17] |
Zhu J, Shi C, Yang D, et al. Internal migration and leprosy in Shanghai from 2000 to 2019: an epidemiological study of new cases[J]. Acta Derm Venereol, 2021,101(5):adv00459. doi: 10.2340/00015555⁃3821.
|
[18] |
Xiong M, Li M, Zheng D, et al. Evaluation of the economic burden of leprosy among migrant and resident patients in Guangdong province, China[J]. BMC Infect Dis, 2017,17(1):760. doi: 10.1186/s12879⁃017⁃2869⁃8.
|
[19] |
Alemu Belachew W, Naafs B. Position statement: LEPROSY: diagnosis, treatment and follow⁃up[J]. J Eur Acad Dermatol Venereol, 2019,33(7):1205⁃1213. doi: 10.1111/jdv.15569.
|
[20] |
Shui TJ, Long H, Xiong L, et al. Towards the elimination of leprosy in Yunnan, China: a time⁃series analysis of surveillance data[J]. PLoS Negl Trop Dis, 2021,15(3):e0009201. doi: 10.1371/journal.pntd.0009201.
|
[21] |
Wang L, Jiang HQ, Hao DF, et al. Monitoring and detection of leprosy patients in Southwest China: a retrospective study, 2010-2014[J]. Sci Rep, 2018,8(1):11407. doi: 10.1038/s41598⁃018⁃29753⁃4.
|
[22] |
陈欢, 旷燕飞, 余美文. 902例麻风病误诊情况分析[J]. 医学与哲学, 2018,39(14):41⁃43. doi: 10.12014/j.issn.1002⁃0772.2 018.07b.12.
|